Synthesis, Computational Studies, and Anticancer Evaluation of Novel Pyrrole Derivatives
Saurabh Bhardwaj, Shikha Sharma, Anurag AgrawalIntroduction:
Pyrroles are a class of bioactive scaffolds characterized by unique pharmacophores, making them attractive candidates for the development of potent therapeutic agents. Recent research has highlighted their potential as anti-tumour agents, particularly due to their ability to regulate or inhibit specific oncogenic pathways.
Methods:
In this study, a series of novel pyrrole derivatives were synthesized by reacting various 1H-pyrrole-2-carbohydrazide compounds with benzaldehyde. The synthesized compounds were characterized using infrared spectroscopy (IR), mass spectrometry (MS), nuclear magnetic resonance (NMR), and elemental analysis. Their anticancer activity was evaluated through in vitro cytotoxicity assays using the MCF-7 breast cancer cell line. Furthermore, molecular docking studies were conducted against human topoisomerase IIα (α-Topo II), an enzyme crucial for DNA topology regulation and commonly overexpressed in proliferating cancer cells. Docking studies were performed using Schrödinger software (version 2022-4), targeting the ATP-binding site (PDB ID: 1ZXM).
Results:
Several of the synthesized pyrrole derivatives exhibited significant antiproliferative activity, with compound 2f demonstrating the strongest effect, showing an IC₂⁽ value of 8.84 μM against the MCF-7 cell line. Molecular docking revealed that compound 2f had the highest binding affinity toward α-Topo II, with a binding energy of −7.3118 kcal/mol. Molecular dynamics simulations of the 1ZXM–2f complex showed stable interaction patterns and conformational stability, further supporting its potential as a promising inhibitor.
discussion:
This study highlights the strong anticancer potential of pyrrole derivatives, with structural modifications improving their medicinal properties. However, further in vivo studies are needed to clarify their mechanisms and optimize their pharmacological profiles.
Discussion:
The findings indicate that structural modifications of pyrrole derivatives can significantly enhance their anticancer properties. The incorporation of a succinimide moiety contributed to stronger interactions within the ATP-binding pocket of α-Topo II, primarily through hydrogen bonding. While the in vitro and in silico results are promising, further in vivo studies are essential to confirm the therapeutic potential of these compounds and to optimize their pharmacological profiles.
Conclusion:
This study highlights the strong anticancer potential of pyrrole derivatives, with structural modifications improving their medicinal properties. However, further in vivo investigations are required to fully elucidate their mechanisms and optimize their pharmacological profiles.